prednisolone acetate has been researched along with Cancer of Prostate in 1 studies
prednisolone acetate: RN given refers to cpd with locant for acetate group in position 21 & (11 beta)-isomer
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vale, CL | 1 |
| Fisher, DJ | 1 |
| White, IR | 1 |
| Carpenter, JR | 1 |
| Burdett, S | 1 |
| Clarke, NW | 1 |
| Fizazi, K | 1 |
| Gravis, G | 1 |
| James, ND | 1 |
| Mason, MD | 1 |
| Parmar, MKB | 1 |
| Rydzewska, LH | 1 |
| Sweeney, CJ | 1 |
| Spears, MR | 1 |
| Sydes, MR | 1 |
| Tierney, JF | 1 |
1 review available for prednisolone acetate and Cancer of Prostate
| Article | Year |
|---|---|
What is the optimal systemic treatment of men with metastatic, hormone-naive prostate cancer? A STOPCAP systematic review and network meta-analysis.
Topics: Abiraterone Acetate; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Disease P | 2018 |